Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Roche Holding (OtherRHHBY), Nutriband (NTRB) and REPRO-MED Systems (KRMD)

Tipranks - Tue Apr 7, 8:34AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Roche Holding (RHHBY), Nutriband (NTRB) and REPRO-MED Systems (KRMD) with bullish sentiments.

Easter Sale - 70% Off TipRanks

Roche Holding (RHHBY)

In a report issued on April 2, Jasper Hellweg from Argus Research upgraded Roche Holding to Buy, with a price target of $55.00. The company’s shares closed last Thursday at $49.85.

According to TipRanks.com, Hellweg is a 4-star analyst with an average return of 7.7% and a 55.4% success rate. Hellweg covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, United Therapeutics, and Novo Nordisk. ;'>

Roche Holding has an analyst consensus of Hold, with a price target consensus of $56.75, a 14.2% upside from current levels. In a report issued on March 21, TipRanks – xAI also upgraded the stock to Buy with a $55.00 price target.

See the top stocks recommended by analysts >>

Nutriband (NTRB)

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Nutriband, with a price target of $15.00. The company’s shares closed last Thursday at $3.63, close to its 52-week low of $3.20.

According to TipRanks.com, LeBoyer is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -8.5% and a 28.8% success rate. LeBoyer covers the Healthcare sector, focusing on stocks such as Neurosense Therapeutics Ltd., Cadrenal Therapeutics, Inc., and MAIA Biotechnology, Inc. ;'>

Nutriband has an analyst consensus of Moderate Buy, with a price target consensus of $15.00.

REPRO-MED Systems (KRMD)

Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems today and set a price target of $8.00. The company’s shares closed last Thursday at $4.32.

According to TipRanks.com, Takkinen is ranked 0 out of 5 stars with an average return of -2.9% and a 37.5% success rate. Takkinen covers the Healthcare sector, focusing on stocks such as Anteris Technologies Global Corp., Adagio Medical Holdings, and TriSalus Life Sciences. ;'>

REPRO-MED Systems has an analyst consensus of Strong Buy, with a price target consensus of $6.75.

Read More on RHHBY:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.